Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma

Authors

Dirk Schadendorf (ORCID: https://orcid.org/0000-0003-3524-7858)
Alpaslan Tasdogan (ORCID: https://orcid.org/0000-0003-2543-852X)
Selma Ugurel (ORCID: https://orcid.org/0000-0002-9384-6704)

Institutions

Düsseldorf University Hospital (DE)
Essen University Hospital (DE)
West German Heart and Vascular Center Essen (DE)
Heinrich Heine University Düsseldorf (DE)
University of Duisburg-Essen (DE)

Publication Details

Journal: JAAD Case Reports
Published: 2024-11-26
DOI: https://doi.org/10.1016/j.jdcr.2024.11.002
Primary Topic: melanin and skin pigmentation
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma

Dirk Schadendorf, Alpaslan Tasdogan, Selma Ugurel

Nov 26, 2024

JAAD Case Reports

melanin and skin pigmentation

article

Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma

Dirk Schadendorf, Alpaslan Tasdogan, Selma Ugurel

November 26, 2024article en

Abstract

No abstract available for this paper.

JAAD Case ReportsVol. 55

Düsseldorf University Hospital (DE), Essen University Hospital (DE), West German Heart and Vascular Center Essen (DE), Heinrich Heine University Düsseldorf (DE), University of Duisburg-Essen (DE)

Zero hunger

Openalex Percentile: Top 78%

melanin and skin pigmentation

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.